Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Obesity May Protect Against Joint Damage in Rheumatoid Arthritis
Link ID 1207
Title Obesity May Protect Against Joint Damage in Rheumatoid Arthritis
Url http://www.medscape.com/viewarticle/566506?src=rss
Description Joint damage due to rheumatoid arthritis (RA) appears to be more severe among patients with a normal body mass index (BMI) than among their obese counterparts, a German research team reports. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Nov 30, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Infliximab Improves Symptoms of Ankylosing Spondylitis, but Damage Continues
  In patients with ankylosing spondylitis, infliximab does not inhibit structural damage, although it may have other beneficial effects, according to European and US researchers. Reuters Health Information
Category:   Articles > Rheumatology


2. (Mis)Understanding in Patient-Health Care Provider Communication About Total Knee Replacement
  Health care providers and patients differ on views of knee replacement
Arthritis Care Research News Alerts
Category:   Articles > Rheumatology


3. Systemic Lupus Erythematosus Patients Exhibit Functional Deficiencies of Endothelial Progenitor Cell
  Endothelial progenitor cells (EPCs) are described to serve as a biomarker for CV risk. Since CV risk is seen in Systemic lupus erythematosus (SLE), would SLE be associated with altered EPC levels?
Rheumatology
Category:   Articles > Rheumatology


4. Evaluating Quality of Life in Dermatomyositis
  How severely is quality of life affected for patients with dermatomyositis? How can it best be measured? Expert Review of Dermatology
Category:   Articles > Rheumatology


5. Anti-IL-12/23 Monoclonal Antibody Useful for Psoriatic Arthritis
  Treatment with ustekinumab, a monoclonal antibody against interleukins 12 and 23, can reduce the signs and symptoms of psoriatic arthritis and is well tolerated, according to a report in the February 12th online issue of The Lancet. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS